WA
Consensus Narrative from 7 Analysts
CDMO And Inhalation Anesthesia Expansion Will Strengthen Future Prospects
Key Takeaways Innovation and on-patent manufacturing in CDMO business are set to drive future revenue and improve EBITDA margins through operating leverage. Expansion in inhalation anesthesia and investment in India Consumer Healthcare fuel growth, while cost optimization and sustainability initiatives enhance margins.
View narrative₹306.29
FV
33.3% undervalued intrinsic discount14.66%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
13 days ago author updated this narrative